ArriVent
formerly ArriVent BioPharmaIPOHome - ArriVent BioPharma
Public · Newtown Square, United States · Founded 2021 · $305.0M raised
- Headquarters
- Newtown Square, Pennsylvania
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- arrivent.com
- Total Funding
- $305.0M
- Last Round
- $155.0M Series BMar 2023
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
ArriVent BioPharma was founded in 2021 to identify, develop, and commercialize differentiated medicines from around the world — particularly innovative therapies initially developed in China, Europe, South Korea, and Japan that might not otherwise reach global patients. The company applies deep oncology expertise and regulatory knowledge to in-license clinical-stage candidates with strong biological rationale and a clear path to approval.
Summary
ArriVent is a Biotech company based in Newtown Square, United States, founded in 2021. It has raised $305.0M in total across 2 rounds, most recently a $155.0M Series B round in Mar 2023. Investors include General Catalyst, Sofinnova Investments and Hillhouse Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jul 2025
Sign up to see all 5 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
General Catalyst
2 rounds
Sofinnova Investments
1 round
Hillhouse Capital
1 round
Hillhouse Capital Group
1 round
Lilly Asia Ventures
2 rounds
OrbiMed
2 rounds
Octagon Capital Advisors
2 rounds
Boyu Capital
2 rounds
Zoo Capital
2 rounds
Sirona Capital
1 round
Catalio Capital Management
1 round
HBM Healthcare Investments
1 round
Shanghai Healthcare Capital
1 round
Sequoia Capital
1 round
Eli Lilly
1 round
Sequoia China
1 round
Infinitum Asset Management
1 round
AIHC Capital
1 round
Unicorn Capital Partners
1 round
Lyra Ventures
1 round
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arrivent"><img src="https://indexed.vc/api/badge/company/arrivent" alt="ArriVent on Indexed.vc" width="260" height="76" /></a>